Home
>
US Stocks
>
MeiraGTx Holdings plc
MeiraGTx Holdings plc
MGTX

MeiraGTx Holdings plc

$18.5939.77%

1D

1W

1M

1Y

3Y

5Y

Key Stats

Open
17.38
Today Low/High
16.73 / 18.92
52 Week Low/High
$11.81 / $18.45
Market Cap
$564.13M

Company Details

MeiraGTx is a vertically integrated, clinical stage gene therapy company with six programs in clinical development and a broad pipeline of preclinical and research programs. MeiraGTx has core capabilities in viral vector design and optimization and gene therapy manufacturing, as well as a potentially transformative gene regulation technology. Led by an experienced management team, MeiraGTx has taken a portfolio approach by licensing, acquiring and developing technologies that give depth across both product candidates and indications. MeiraGTx's initial focus is on three distinct areas of unmet medical need: ocular, including inherited retinal diseases and large degenerative diseases, neurodegenerative diseases and severe forms of xerostomia. Though initially focusing on the eye, central nervous system and salivary gland, MeiraGTx intends to expand its focus in the future to develop additional gene therapy treatments for patients suffering from a range of serious diseases.
Organisation
MeiraGTx Holdings plc
Headquaters
New York, New York, US
Employees
219
Industry
Health Technology
CEO
Alexandria Forbes

Discover more

Frequently Asked Questions

What is MeiraGTx Holdings plc share price today

Can Indians buy MeiraGTx Holdings plc shares?

How can I buy MeiraGTx Holdings plc shares from India?

Can Fractional shares of MeiraGTx Holdings plc be purchased?

What are the documents required to start investing in MeiraGTx Holdings plc stocks?

We are a SEBI registered investement advisor